...to about $50 million. Existing investors Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling...

...investors Asahi Kasei Pharma Corp. and Mission Bay Capital also participated, as did existing investors Sanderling...
...Pharmaceutical Inc. (NASDAQ:BMRN) and Raptor Pharmaceutical Corp. co-founder Chris Starr. Glycomine raised $12 million from Sanderling...

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling...

...the financing. New investors TPG Capital and RA Capital also participated, as did existing investor Sanderling...

...Inc. (Montreal, Quebec) said it completed an undisclosed seed financing in late August led by Sanderling...
...allogeneic hematopoietic stem cell transplantation. SpecificiT also said it named Pierre Beauparlant, venture partner at Sanderling...

...$28.6 million) on July 27 in an oversubscribed series A round led by Arix Bioscience. Sanderling...

...raised C$36 million ($28.6 million) in an oversubscribed series A round led by Arix Bioscience. Sanderling...
...NYSE:SNY). In May, PreciThera raised seed funding in the form of a consolidated loan from Sanderling...

...Family Office, AstraZeneca plc, other undisclosed investors DalCor Pharma U.K. Ltd. (U.K.) Series B $100.0 Sanderling...

...Paul Scherrer Institute Corporate partners: N/A Number of employees: 3 Funds raised: Undisclosed Investors: Sanderling...

...Glycomine raised $12 million in a series A round led by Sanderling Ventures . Chiesi Ventures...